相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients
Leni van Doorn et al.
PHARMACEUTICALS (2021)
Prognostic significance of radiodensity-based skeletal muscle quantification using preoperative CT in resected non-small cell lung cancer
Eun Young Kim et al.
JOURNAL OF THORACIC DISEASE (2021)
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
A Deep Learning Model to Automate Skeletal Muscle Area Measurement on Computed Tomography Images
Kaushalya C. Amarasinghe et al.
FRONTIERS IN ONCOLOGY (2021)
Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC
R. Mallet et al.
SCIENTIFIC REPORTS (2021)
Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics
Laura Molenaar-Kuijsten et al.
CANCER MEDICINE (2021)
Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma
Anna C. H. Willemsen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
Alice Avancini et al.
ONCOLOGIST (2020)
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies
Elena Conte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer
Tarje Onsoien Halvorsen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Genetic variants as predictors of toxicity and response in patients with non-small cell lung cancer undergoing first-line platinum-based chemotherapy: Design of the multicenterPGxLUNGstudy
Corine de Jong et al.
THORACIC CANCER (2020)
The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis
Laura F. J. Huiskamp et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Prognostic Value of Sarcopenia in Lung Cancer A Systematic Review and Meta-analysis
Ming Yang et al.
CHEST (2019)
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients
Sophie Kurk et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer
Aniek T. Zwart et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients
D. Portal et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer
Yo Kawaguchi et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2019)
Sarcopenia as Prognostic Factor in Lung Cancer Patients: A Systematic Review and Meta-analysis
Judith Buentzel et al.
ANTICANCER RESEARCH (2019)
Does sarcopenia have any impact on survival of patients with surgically treated non-small-cell lung cancer?
Han-Yu Deng et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2019)
Frailty and skeletal muscle in older adults with cancer
Grant R. Williams et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Contrast-enhancement influences skeletal muscle density, but not skeletal muscle mass, measurements on computed tomography
Jeroen L. A. van Vugt et al.
CLINICAL NUTRITION (2018)
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer
Bjorg Sjoblom et al.
CLINICAL LUNG CANCER (2017)
Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value
Drazena Srdic et al.
SUPPORTIVE CARE IN CANCER (2016)
Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens
Raafi Ali et al.
CANCER MEDICINE (2016)
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
J. Aubrey et al.
ACTA PHYSIOLOGICA (2014)
Mechanisms of cisplatin-induced muscle atrophy
Hiroyasu Sakai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Drug therapy: Multidisciplinary management of lung cancer
A Spira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Performance status score: do patients and their oncologists agree?
SP Blagden et al.
BRITISH JOURNAL OF CANCER (2003)
Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
M Ando et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
